Citations

Mayo Clinic

Showing 10 of 108572 citations.

Total Migraine Freedom for Breath Powered Intranasal Delivery System Containing 22 mg Sumatriptan Powder (AVP-825) vs 100 mg Oral Sumatriptan from the COMPASS Study of Acute Treatment of Migraine (I3.009)
Halker, Rashmi, Tepper, Stewart J. , Shulman, Kenneth, Wallick, Christopher J.

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i3.009 Get It

Prevention of Episodic Migraine with AMG 334, a Human Anti-Calcitonin Gene-Related Peptide Receptor Monoclonal Antibody: Phase 2 Study Results and 52-Week Analysis of Open-Label Extension (I3.001)
Lenz, Robert , Silberstein, Stephen D., Saper, Joel R., Cady, Roger , Trotman, Marie‐Louise, Dietrich, Julie , Sun, Hong , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe , Ashina, Messoud , Zhang, Feng

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i3.001 Get It

Cascading Network Failure across the Alzheimer’s Disease Spectrum (I12.010)
Jones, David , Gunter, Jeffery, Graff‐Radford, Jonathan , Petersen, Ronald, Weiner, Michael W. , Knopman, David S. , Vemuri, Prashanthi , Boeve, Bradley F. , Petersen, Ronald, Jack, Clifford R.

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i12.010 Get It

Biomarker Confirmed Alzheimer’s Disease Presenting as Amnestic, Aphasic, and Visual Variants: Hippocampal Volume Comparison (I12.009)
Butts, Alissa M. , Strand, Edythe, Drubach, Daniel A., Przybelski, Scott A. , Petersen, Ronald C. , Lowe, Val J. , Josephs, Keith A. , Whitwell, Jennifer , Machulda, Mary M. , Duffy, Joseph R. , Jack, Clifford R.

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i12.009 Get It

Literature Review of Genetic Disorders with tau Pathology (I12.004)
Tacik, Paweł , Rademakers, Rosa , Wszołek, Zbigniew K. , Sánchez-Contreras, Mónica , Dickson, Dennis W.

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i12.004 Get It

Multimorbidity and Neuroimaging Biomarkers Among Cognitively Normal Persons (I12.002)
Vassilaki, Maria , Aakre, Jeremiah A. , Alhurani, Rabe E., Petersen, Ronald C. , Lowe, Val J. , Roberts, Rosebud O., Mielke, Michelle M. , Geda, Yonas E. , Kremers, Walter K. , Machulda, Mary M. , Knopman, David S. , Jack, Clifford R.

Neurology | December 7, 2023 | Volume: 86 | Issue: 16_supplement | Pages: No page available

10.1212/wnl.86.16_supplement.i12.002 Get It

Quadriceps fatigue during hypoxic and ischemic knee-extension exercise is similar in males and females
Dominelli, Paolo B. , Senefeld, Jonathon W. , Wiggins, Chad C. , Baker, Sarah E. , Clayburn, Andrew J. , Joyner, Michael J. , Wiggins, Chad C , Joyner, Michael J , Senefeld, Jonathon W , Baker, Sarah E

Journal of Applied Physiology | December 7, 2023 | Volume: 136 | Issue: 1 | Pages: 177-188

10.1152/japplphysiol.00656.2023 | PMID 38059290 Get It

Hypoxia exacerbates fatigue via central mechanisms after ischemic single-leg exercise. The greater fatigue observed during ischemic dynamic fatiguing exercise with hypoxia inspirate did not differ between the sexes. Hypoxia-induced central limitations are present in acute ischemic exercise and do not appear different in males and females.
Teaching NeuroImages: Rete-like middle cerebral artery
Colombo, Elisa , Brinjikji, Waleed , Klaas, James P. , Lanzino, Giuseppe , Klaas, James P , Lanzino, Giuseppe

Neurology | December 7, 2023 | Volume: 93 | Issue: 20 | Pages: No page available

10.1212/wnl.0000000000008480 | PMID 31712382 Get It

Therapeutic Consequences of Targeting the IGF-1/PI3K/AKT/FOXO3 Axis in Sarcopenia: A Narrative Review
Gellhaus, Benjamin , Böker, Kai O. , Schilling, Arndt F. , Saul, Dominik , Schilling, Arndt Friedrich , Saul, Dominik

Cells | December 7, 2023 | Volume: 12 | Issue: 24 | Pages: 2787

10.3390/cells12242787 | PMID 38132107 Get It

The high prevalence of sarcopenia in an aging population has an underestimated impact on quality of life by increasing the risk of falls and subsequent hospitalization. Unfortunately, the application of the major established key therapeutic—physical activity—is challenging in the immobile and injured sarcopenic patient. Consequently, novel therapeutic directions are needed. The transcription factor Forkhead-Box-Protein O3 (FOXO3) may be an option, as it and its targets have been observed to be more highly expressed in sarcopenic muscle. In such catabolic situations, Foxo3 induces the expression of two muscle specific ubiquitin ligases (Atrogin-1 and Murf-1) via the PI3K/AKT pathway. In this review, we particularly evaluate the potential of Foxo3-targeted gene therapy. Foxo3 knockdown has been shown to lead to increased muscle cross sectional area, through both the AKT-dependent and -independent pathways and the reduced impact on the two major downstream targets Atrogin-1 and Murf-1. Moreover, a Foxo3 reduction suppresses apoptosis, activates satellite cells, and initiates their differentiation into muscle cells. While this indicates a critical role in muscle regeneration, this mechanism might exhaust the stem cell pool, limiting its clinical applicability. As systemic Foxo3 knockdown has also been associated with risks of inflammation and cancer progression, a muscle-specific approach would be necessary. In this review, we summarize the current knowledge on Foxo3 and conceptualize a specific and targeted therapy that may circumvent the drawbacks of systemic Foxo3 knockdown. This approach presumably would limit the side effects and enable an activity-independent positive impact on skeletal muscle.
Novel Method of Dual-innervated Free Gracilis Muscle Transfer for Facial Reanimation: A Case Series
Hebel, Nathan , Boonipat, Thanapoom , Robertson, Carrie E. , Meaike, Jesse D. , Meaike, Jesse, Robertson, Carrie E , Asaad, Malke , Gibreel, Waleed , Mardini, Samir

Plastic and Reconstructive Surgery - Global Open | December 7, 2023 | Volume: 11 | Issue: 12 | Pages: e5388

10.1097/gox.0000000000005388 | PMID 38074495 Get It

Background: Dynamic facial reanimation is the gold standard treatment for a paralyzed face. The use of the cross-face nerve graft (CFNG) in combination with the masseteric nerve to innervate the free gracilis muscle has been reported to provide both spontaneity and strong neural input. We report a case series of dual innervation, using a novel method where the branch to masseter is coapted to the side of the CFNG. Methods: Eight patients received free gracilis muscle transfer using the new dual innervation method between September 2014 and December 2017. The CFNG, which was performed nine months prior, was sutured in an end-to-end fashion to the obturator nerve. A nerve graft was coapted to the ipsilateral masseteric nerve and then sutured in an end-to-side fashion to the CFNG proximal to its coaptation to the obturator nerve. Results: All patients recovered smile function with and without teeth clenching around the same time period. Smiles without teeth clenching appeared later in two of eight patients and earlier in one of eight patients, being noted at an average of 8.25 months of follow-up versus 7.6 months. The estimate of true attainment is limited by the spacing of follow-up dates. Average follow-up time was 36.07 months (range: 10–71.5). FACE-Gram software smile analysis with and without biting demonstrated similar excursion on average (7.64 mm versus 8.6 mm respectively, P = 0.93), both of which are significantly improved from preoperation. Conclusion: This novel method of a dual-innervated free gracilis muscle transfer offers a viable technique that achieves a symmetric, strong, and emotional smile.